TP53 and cancer: For one of the most commonly used gene therapy vectors, adenovirus (Ad), two Ad-based vectors have been approved for cancer treatment in China—a non-replicating Ad encoding p53, termed Gendicine, and an oncolytic Ad that selectively replicates in cancer cells, termed Oncorine [15,16].